Lancet 374, 16061616
However, the approach differs significantly if you've missed multiple doses or have been off treatment for an extended period
Oral cyanocobalamin supplementation (typically 50150 micrograms daily) represents an appropriate option for patients with dietary deficiency without intrinsic factor deficiency or malabsorption issues
Contraindications Based on Mechanism Active mental health crisis or suicidal ideation (unproven intervention should never delay evidence-based emergency care) Pregnancy or breastfeeding (no safety data, potential for developmental effects given neuroprotective/neuroplastic actions) Bleeding disorders (BPC-157 affects thrombocyte function) Immune system disorders (concerns about potential immune reactions) Frequently Asked Questions What is BPC-157 and where does it come from
Patients received an initial dose of either 1 mg, 2 mg, or 4 mg of retatrutide and subsequent doses of either 1 mg, 4 mg, 8 mg, or 12 mg, or they received a placebo throughout the 48 weeks of the study
Suitable for Various Diets: